Veradigm’s delisting came after the company failed to report quarterly or annual earnings results with regulators since November 2022, a lapse the company attributed to “internal control failures.” ...
The executive shakeup comes amid an independent investigation conducted by legal counsel into Veradigm’s financial reporting and disclosure controls. The company failed to file its annual report for ...
McKesson (NYSE:MCK) and Oracle (NYSE:ORCL) are among the finalists seeking to acquire electronic medical records company Veradigm (OTC:MDRX), Axios reported Sunday, citing sources. According to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results